About us

Perfusion Tech
in brief

PerfusionTech is a Copenhagen-based MedTech company established in 2016
Company developes and markets image analysis software for intrasurgical perfusion quantification and visualization
PerfusionWorks software for real-time perfusion quantification in selected areas is available for sales within Europe
PerfusionWorks software for blood vessel mapping is available to the market by 2024

Perfusion Tech in brief

PerfusionTech is a Copenhagen-based MedTech company established in 2016

Company developes and markets image analysis software for intrasurgical perfusion quantification and visualization

PerfusionWorks software for real-time perfusion quantification in selected areas is available for sales within Europe

PerfusionWorks software for blood vessel mapping is available to the market by 2026

2016
PerfusionTech established Filing of patent #1: “System and method for assessing perfusion in an anatomical structure”.
2018
Filing of patent #2: “System and method for automatic perfusion measurement”
2019
End feasibility study within colorectal cancer surgery

Filing of patent #3: “System and method for identifying blood vessels during fluorescence imaging”
2020
End clinical study within colorectal cancer surgery
 
CE-marking of PerfusionWorks within colorectal cancer surgery
2021
Filing of patent #4: “System and method for identifying an abnormal perfusion pattern”

CE-mark on PerfusionWorks extended to cover a broad range of surgical specialties

Initiation of 150 patients multicenter study “QUANTICO” within colorectal cancer surgery
2022
Filing of patent #5: “System and method for lymph node mapping”

Eurostars Grant obtained with DK/NL syndicate Pre-clinical studies on the use of micro-dosing technology initiated

First software installations at customers

ISO 13485 Stage 1 audit passed
2023
ISO 13485 Certified (BSI)

Partnership with strategic investor and commercialisation partner Renew Health Ltd. initiated
2024
Last patient included in "QUANTICO" multicenter study within colorectal cancer surgery

Submission for CE-marking under MDR
OUR STORY SO FAR

Perfusion Tech’s journey

2022:
Filing of patent #5: “System and method for lymph node mapping”
Eurostars Grant obtained with DK/NL syndicate
Pre-clinical studies on the use of micro-dosing technology initiated
First software installations at customers
ISO 13485 Stage 1 audit passed

Customer Name

Company Name

2021:
Filing of patent #4: “System and method for identifying an abnormal perfusion pattern”
CE-mark on PerfusionWorks extended to cover a broad range of surgical specialties
initiation of 250 pts multicenter study “QUANTICO” within colorectal cancer surgery

Customer Name

Company Name

2020:
End clinical study within colorectal cancer surgery
CE-marking of PerfusionWorks within colorectal cancer surgery

Customer Name

Company Name

2019:
End feasibility study withincolorectal cancer surgery
Filing of patent #3: “Systemand method for identifying blood vessels during fluorescence imaging”

Customer Name

Company Name

2018:
Filing of patent #2: “Systemand method for automatic perfusion measurement”

Customer Name

Company Name

2016:
PerfusionTech established
Filing of patent #1: “Systemand method for assessing perfusion in an anatomical structure”.

Customer Name

Company Name

PerfusionTech’s
patent portfolio

why choose north?

"PerfusionTech has been a life saver from day one. We now have clear overview of all our activities"

Esther Howard

Founder, Truely

Want to get in touch?